Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2000, p. 632-637, Vol. 66, No. 2
Departments of
Pathobiology1 and Large Animal Surgery
and Medicine,3 College of Veterinary Medicine,
Auburn University, Auburn, Alabama 36849; Department of Food
Microbiology and Toxicology, Food Research Institute, University of
Wisconsin, Madison, Wisconsin 537062; and
Department of Microbiology and Immunology, University of South
Alabama College of Medicine, Mobile, Alabama
366884
Received 9 August 1999/Accepted 18 November 1999
Acid resistance (AR) is important to survival of Escherichia
coli O157:H7 in acidic foods and may play a role during passage through the bovine host. In this study, we examined the role in AR of
the rpoS-encoded global stress response regulator
Escherichia coli O157:H7
is a member of the enterohemorrhagic group of pathogenic E. coli (EHEC). This agent has emerged as a food-borne and waterborne
pathogen of humans that causes hemorrhagic colitis, hemolytic-uremic
syndrome, and thrombotic thrombocytopenic purpura. Outbreaks involving
undercooked ground beef (1) and a variety of other foods
including salami (7) and apple cider (3) have
been documented.
Most human disease outbreaks caused by this organism have been linked
to bovine fecal contamination of food or water. E. coli O157:H7 inhabits the intestinal tract of cattle, but it is unclear whether it actually colonizes the bovine intestinal tract
(31). This organism seldom causes disease in cattle
(10). Prevalence in individual beef and dairy cattle in the
United States is low, from 0.3 to 2.2% (14, 20, 21).
E. coli O157:H7 exists on about 7% of farms
(14). Typically, shedding of serotype O157:H7 strains from
cattle is sporadic and of limited duration, lasting for approximately 1 month (2, 31).
A number of animal models have been used to assess the pathogenesis and
shedding of E. coli O157:H7 strains, including greyhounds (15), mice (33), neonatal calves (11),
gnotobiotic pigs (16), and sheep (24). A
modification of the streptomycin-treated mouse model described by Myhal
and coworkers (29, 30) has been used to compare the
colonization of E. coli O157:H7 strain 933 with that of
strain 933cu, which was cured of pO157 (33). Results from
these animal models have been useful in elucidating the mechanisms of
virulence and pathology.
Most E. coli O157:H7 strains contain the eae
locus, which encodes the adhesin protein intimin (12). The
eae gene also is found in the enteropathogenic group of
E. coli (23). The recent finding that intimin is
required for E. coli O157:H7 attachment in the bovine
intestinal tract in neonatal calves has led one group of investigators
to suggest that an anti-intimin vaccine might be effective for reducing
the level of this pathogen in herds (12). In addition to
intimin, E. coli O157:H7 also produces Shiga-like toxins,
which may play a role in the lesions seen in the gut and kidneys of
infected humans. E. coli O157:H7 is thought to have a low
infectious dose ( Two recent studies have investigated the effect of diet on AR of
E. coli shed from cattle. Diez-Gonzalez and coworkers
(13) examined the effect of high-grain diets on shedding of
acid-resistant E. coli from cattle. They found that the
proportion of acid-resistant E. coli increased in cattle fed
a high-grain diet, but that a switch to a diet of hay decreased the
number of acid-resistant bacteria. It is unclear if the results
observed for E. coli in these experiments are relevant to
serotype O157 strains of E. coli. Hovde et al.
(22) examined the AR and the duration of shedding of
E. coli O157:H7 from experimentally inoculated cattle fed
hay or grain. They found no difference in the proportion of acid-resistant E. coli O157:H7 between these two groups but
observed that animals fed hay shed E. coli O157:H7 longer
than animals fed grain. Further studies are needed to clarify the role
played by AR on E. coli O157:H7 shedding from cattle.
EHEC strains contain three distinct AR systems (26). The
oxidative or glucose-repressed system (AR system 1) is active when the
cells are growing aerobically or anaerobically in the absence of
glucose. In contrast, the glutamate-dependent (AR system 2) and
arginine-dependent (AR system 3) systems are active during fermentation. All three systems are active during stationary-phase growth, which suggests the involvement of the alternate,
stationary-phase sigma factor In the present study, the role of resistance to acid stress in E. coli O157:H7 gastrointestinal passage in mice and shedding in
calves was examined. We tested the hypothesis that rpoS
regulates one or more of the AR systems in E. coli O157:H7
and that a mutation in rpoS would affect the ability of the
organism to survive in mice and calves. The results indicate that
rpoS regulates especially the glucose-repressed AR system
and is important to passage and shedding of E. coli O157:H7
in mice and calves, respectively, possibly by inducing resistance to
gastrointestinal acid stress.
(Portions of this work have been presented elsewhere [J. Minter,
S. C. Richardson, F. J. DeGraves, J. C. Wright, T. A. Penfound, J. W. Foster, and S. B. Price, Abstr. 98th Gen.
Meet. Am. Soc. for Microbiol. 1998, abstr. B-169, p. 81, 1998].)
Bacterial strains.
The E. coli strains used in
this study are listed in Table 1.
E. coli O157:H7 strain ATCC 43895, originally isolated from raw hamburger meat implicated in a hemorrhagic colitis outbreak (strain
933 [34]), was used throughout the study. An
rpoS mutant of this strain (FRIK 816-3 [8])
was constructed by insertional inactivation with pRR10, which carries
the gene encoding
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Role of rpoS in Acid Resistance and
Fecal Shedding of Escherichia coli O157:H7

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
S and its effect on shedding of E. coli
O157:H7 in mice and calves. When assayed for each of the three AR
systems identified in E. coli, an rpoS mutant
(rpoS::pRR10) of E. coli O157:H7
lacked the glucose-repressed system and possessed reduced levels of
both the arginine- and glutamate-dependent AR systems. After
administration of the rpoS mutant and the wild-type strain
(ATCC 43895) to ICR mice at doses ranging from 101 to
104 CFU, we found the wild-type strain in feces of mice
given lower doses (102 versus 103 CFU) and at a
greater frequency (80% versus 13%) than the mutant strain. The
reduction in passage of the rpoS mutant was due to decreased AR, as administration of the mutant in 0.05 M phosphate buffer facilitated passage and increased the frequency of recovery in
feces from 27 to 67% at a dose of 104 CFU. Enumeration of
E. coli O157:H7 in feces from calves inoculated with an
equal mixture of the wild-type strain and the rpoS mutant demonstrated shedding of the mutant to be 10- to 100-fold lower than
wild-type numbers. This difference in shedding between the wild-type
strain and the rpoS mutant was statistically significant (P
0.05). Thus,
S appears to play a
role in E. coli O157:H7 passage in mice and shedding from
calves, possibly by inducing expression of the glucose-repressed RpoS-dependent AR determinant and thus increasing resistance to gastrointestinal stress. These findings may provide clues for future
efforts aimed at reducing or eliminating this pathogen from cattle herds.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
200 organisms) in humans (19). As with
other enteric pathogens, the infectious dose for E. coli O157:H7 is thought to correlate with acid resistance (AR)
(18). Because E. coli O157:H7 survives in acidic
foods and has a low infectious dose, we hypothesize that it can resist
gastric acidity in cattle and that AR is another virulence mechanism of
this pathogen.
S, which is encoded by
rpoS.
S is now known to play a protective
role when E. coli O157:H7 is exposed to a variety of
environmental stresses, including acid (8).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactamase. A gadA mutant of ATCC 43895 was constructed in a similar manner as described by Castanie-Cornet et
al. (6). The location of the gadA insertion was
confirmed using PCR and primers that amplified the correct fragment
size only if the insertion had occurred in gadA. Spontaneous
mutants of the rpoS and gadA strains resistant to
nalidixic acid and rifampin were generated to aid in recovery from calf
fecal specimens. Ampicillin (50 µg/ml) was added to cultures of these
mutants to maintain pRR10.
TABLE 1.
E. coli strains used in this study
AR assays. Cells were grown overnight in one of several media: LBG (Luria-Bertani [LB] plus 0.4% glucose), BHIG (brain heart infusion [BHI] plus 0.4% glucose), LB or BHI buffered with either 100 mM morpholinepropanesulfonic acid [pH 8] or 100 mM morpholineethanesulfonic acid [pH 5.5] [28]), and minimal E glucose (EG [32]). Cultures were grown in 3 ml of the appropriate medium in 13-mm test tubes with shaking (240 rpm) at 37°C to stationary phase (22 h). The glucose-repressed system was tested using cells grown overnight in pH 5.5 buffered LB or BHI followed by 1:1,000 dilution into prewarmed (37°C) pH 2.5 EG. The glutamate and arginine systems were tested using stationary-phase cells grown in LBG followed by 1:1,000 dilution into prewarmed pH 2.5 EG supplemented with 1.5 mM glutamate or 0.6 mM arginine, respectively. Viable-cell counts were determined at 0, 2, and 4 h post-acid challenge by diluting cells in LB, plating cells onto LB agar, and incubating plates for 20 h at 37°C. Values given are representative of the results of triplicate experiments reproducible to within 50%.
Mouse inoculation studies.
A modified version of a
previously described procedure (33) was used for oral
administration of E. coli O157:H7 strains 43895 (RpoS+) and FRIK 816-3 (RpoS
). Bacteria were
grown in Trypticase soy broth (BBL Microbiology Systems, Cockeysville,
Md.) at 37°C with shaking (150 rpm) to stationary phase. The cells
were harvested by centrifugation (10,000 × g, 10 min)
and diluted to the appropriate concentration in a 10% sucrose solution
or 0.05 M phosphate buffer (7.2 g of Na2HPO4, 1.2 g of KH2PO4 [pH 7.4]) containing
10% (wt/vol) sucrose. ICR mice (ca. 20 g; Harlan Sprague Dawley
Inc., Madison, Wis.) were housed individually in cages with grated
floors so that feces could be collected from sterile liners on trays
below the cages. The mice were deprived of feed for 24 h
preinoculation and then provided a sterile plate containing the sucrose
cell suspension (0.5 ml) with numbers of E. coli O157:H7
cells ranging from 0 cells (control) to 104 CFU. Some mice
received strain FRIK 816-3 in 10% sucrose containing 0.05 M phosphate
buffer to ensure that susceptibility to acid and not another factor was
the cause for reduction in gastrointestinal passage in mice. The mice
were observed to make sure that they consumed the entire inoculum. To
allow for clearance of the inoculum through the stomach and to avoid
any protection to gastric acidity, the mice were not provided feed for
4 h after administration of the inoculum.
Calf inoculation studies. Weaned 6- to 8-week-old calves were acclimated outdoors for 1 week and then moved to an indoor, climate-controlled BL-2 containment facility, where they were acclimated for an additional week prior to inoculation. Pairs of calves were housed together on pine bedding and fed grain and hay in the morning and evening, with water provided ad libitum. Outdoor and indoor pens were cleaned twice daily. Each calf was cultured for E. coli O157:H7 three times before inoculation to ensure that any calves shedding wild strains of the organism were excluded from the study. At the completion of each experiment, the calves were euthanized with sodium pentobarbital and incinerated. Housing and care of the calves followed the guidelines of the American Association for Laboratory Animal Care.
Bacterial strains for inoculation into calves were grown in 12.5 ml of BHI broth (pH 5.5) to stationary phase. Cell pellets were harvested by centrifugation, washed, and suspended in 0.85% NaCl. Calves were inoculated by gastric lavage with a 50-ml inoculum of 0.85% NaCl containing 1010 CFU of an equal mixture of EK274 (RpoS+) and EK275 (RpoS
), followed by 500 ml
of 0.85% NaCl. In a control experiment designed to confirm that pRR10
had no effect on shedding, a mixture of equal amounts of EK274 and
EF501 (gadA) was inoculated into four calves.
Following inoculation, calf fecal samples were cultured daily for 16 days for the presence of E. coli O157:H7. Fifty-gram specimens were collected each morning and immediately transported back
to the laboratory for culture. Quantitative culture of the specimens
was performed by adding 1 g of feces to 9 ml of phosphate buffer
followed by serial 10-fold dilution. A 0.1-ml volume of each dilution
was plated in duplicate onto MSA plates containing nalidixic acid (35 µg/ml), which selected for EK274 and EK275 (or EF501), and MSA plates
containing ampicillin (50 µg/ml), which selected for EK275 or EF501.
Following 16 to 20 h of incubation at 37°C, sorbitol-negative
colonies were counted manually. To determine the quantity of EK274
present in specimens, the number of ampicillin-resistant colonies was
subtracted from the total number of nalidixic acid-resistant colonies.
To detect the organism in feces containing <103 CFU/g,
fecal swabs were enriched in BHI containing novobiocin (20 µg/ml),
potassium tellurite (2.5 µg/ml), and rifampin (25 µg/ml). Following
overnight incubation, the BHI cultures were streaked onto Rainbow Agar
O157 (Biolog, Inc., Hercules, Calif.) containing ampicillin or
nalidixic acid. This medium is an E. coli O157-selective and
differential medium on which colonies of this pathogen turn grey-black.
Using this enrichment technique, the presence in fecal samples of as few as three organisms per fecal swab could be detected. Serologic confirmation of E. coli O157:H7 suspect colonies in both the
direct plating and enrichment culture protocols was made using a
commercial latex agglutination kit (Remel).
Statistical analysis. Data from the mouse experiment were analyzed by analysis of variance using the SAS statistical analysis system (SAS Institute, Inc., Cary, N.C.). Fecal shedding data from the calf study were entered into a spreadsheet program (Microsoft Excel 97 for Windows, version 4.0) and analyzed using SAS. Daily values (CFU per gram of feces) for each strain were converted to log10 for analysis. Total CFU per gram shed over days 1 to 7 was calculated using area under the curve following the trapezoidal rule (17). EK275 (rpoS) shedding as a percentage of EK274 shedding was calculated by dividing area under the curve results from EK275 shedding by area under the curve EK274 shedding and multiplying the result by 100. EF501 (gadA) shedding as a percentage of EK274 shedding was calculated in a similar manner. Differences in percent shedding between EK275 and EF501 were analyzed using Student's t test (36).
| |
RESULTS |
|---|
|
|
|---|
Effect of rpoS on acid resistance of O157.
The
E. coli O157:H7 parent (EK274) and rpoS mutant
(EK275) were tested for the AR systems previously identified
(25). The data presented in Table
2 show that insertional inactivation of
rpoS eliminated the glucose-repressed system (AR system 1) and reduced the arginine- and glutamate-dependent systems to various levels when cells were adapted in LB (pH 5.5) and LBG, respectively. Previous results obtained with an E. coli K12
rpoS mutant were similar to the results reported here with
the serotype O157:H7 rpoS mutant, EK275 (26).
Although an rpoS mutation caused decreased glutamate- and
arginine-dependent AR, these systems do not have an absolute
requirement for RpoS. This was evident when adaptation was made in BHIG
rather than LBG. After growth in BHIG, EK275 exhibited near-normal
levels of glutamate- and arginine-dependent AR (Table 2). Yet, when the
rpoS mutant was adapted in BHI (pH 5.5), it remained
defective in glucose-repressed AR. Clearly, rpoS
inactivation selectively prevents the induction of AR system 1, showing
that this glucose-repressed system is also RpoS dependent. The effect
of adaptation in BHI on AR was also observed in another EHEC strain
(O91:H21) originally thought to lack acid resistance (27).
Strain O91:H21 exhibited no AR when adaptations were performed in LB
(Table 3). However, when adaptations were performed using BHI medium,
this strain exhibited significant levels of all three AR systems (Table
3).
|
|
Passage of E. coli O157:H7 RpoS+ and
RpoS
strains in mice.
Oral administration of
E. coli O157:H7 strains ATCC 43895 (RpoS+
wild-type strain) and FRIK 816-3 (RpoS
) did not result in
visible signs of disease in ICR mice. Feed intake remained constant
(average, 8.3 ± 0.5 g/day), and mice produced a daily average of
2.2 g of feces, of which 0.5 g was tested for the presence of
the E. coli O157:H7 strains. The plating of fecal samples
from mice (control and preinoculation) on MSA+ resulted in low numbers
of background bacteria that were similar to colonies of serotype
O157:H7 strains (i.e., sorbitol negative).
|
Shedding of E. coli O157:H7 RpoS+ and
RpoS
strains in calves.
A quantitative approach was
taken to examine the effect of rpoS on E. coli
O157:H7 shedding patterns from experimentally inoculated calves. In
these experiments, equal amounts of the wild-type (EK274; RpoS+) and RpoS
(EK275) strains were
inoculated into three calves. The animals remained healthy throughout
the experiment. As has been observed previously with inoculation of
E. coli O157:H7 into calves, there was considerable
variation of shedding among the calves (10). The reason for
this variation is unknown.
|
mutant strain was shed in significantly
decreased amounts from all three calves compared to wild-type shedding
(P
0.05). Although shedding of the
RpoS
strain dropped below 103 CFU/g 8 days
earlier than did the RpoS+ strain (Fig. 1), the mutant
could be detected in feces from experimentally infected calves for 15 to 39 days, comparable to the length of parent strain shedding, which
ranged from 17 to 43 days (data not shown).
To confirm that shedding differences observed were due to the
inactivation of rpoS and not the plasmid (pRR10) insert, a
mutant containing pRR10 inserted into the gene for glutamate
decarboxylase (gadA) was constructed. The
gadA mutant (EF501) was fully acid resistant (Table
2). The difference in shedding in four calves between the parent and
the gadA mutant was not significantly different (P > 0.05; Fig. 1), indicating that pRR10 itself had
no effect on shedding. This finding also illustrates the consistency of results when one is comparing two strains with equal ability to survive
passage through the bovine gastrointestinal tract.
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, the role of rpoS in AR and the subsequent impact on shedding of E. coli O157:H7 from mice and calves were examined. Our working hypothesis is that AR in E. coli O157:H7 is induced during passage and growth of the organism in the intestinal tract of cattle (26). This hypothesis has been supported by recent data from Hovde et al. (22), who showed that acid-resistant E. coli O157:H7 was shed from cattle. We have shown previously that once induced, all three AR systems (rpoS dependent, glutamate dependent, and arginine dependent) will persist for at least a month at 4°C (26). Combined, the published data indicate that AR can be induced in the intestinal tract, and growth of acid-resistant E. coli O157:H7 on a contaminated beef carcass is unnecessary for persistence of the phenotype.
The in vitro AR studies reported here extend the findings of a previous study by Cheville et al. (8), which described the construction and characterization of acid tolerance in an rpoS mutant of E. coli O157:H7 (FRIK 816-3). A marked difference in the glucose-repressed AR system between the wild-type and RpoS mutant was observed, confirming a role for rpoS in induction of this system (Table 2). Interestingly, an rpoS effect on the arginine- and glutamate-dependent AR systems in LBG was not found when the wild-type and RpoS mutant strains were acid challenged in BHIG. This finding was not limited to E. coli O157:H7 EHEC, as another EHEC strain, O91:H2, also showed differences in AR in LBG and BHIG.
ICR mice were used in studies to evaluate the influence of the rpoS regulon and acid tolerance on gastrointestinal passage in mice. Mice were used as one of the animals for testing our hypothesis due to the ease of handling and the increased size of groups which this species affords. However, the streptomycin-treated mouse model used by others (29, 33) for colonization and pathogenicity studies was not used because this study concerned passage through the gastric barrier and not colonization. In fact, colonization and subsequent replication would have made results more difficult to interpret. Positive fecal samples from mice were detected at day 1 after inoculation, and only two mice remained fecal positive at day 2. No mice tested positive 3 days after inoculation, which indicates that there was no colonization of mice by either E. coli O157:H7 strain (ATCC 43895 or FRIK 816-3).
Results from inoculation of mice with levels of wild-type strain ATCC 43895 or FRIK 816-3 ranging from 101 to 104 CFU demonstrated that a functional rpoS system promoted survival during gastrointestinal passage in mice. Inoculation of lower numbers of strain 43895 than of FRIK 816-3 resulted in positive fecal samples. Also, the frequency of positive fecal samples was greater in mice inoculated with 43895 when the same number of wild-type and mutant strain was administered (Table 4). For example, 12 of 15 mice (80%) had a positive fecal sample when administered 103 CFU of the wild-type strain, whereas, 2 of 15 (13%) mice given 103 CFU of the rpoS mutant strain FRIK 816-3 tested positive. To ensure that the reduced recovery of FRIK 816-3 was due to acid sensitivity and not another factor detrimental to passage, the mutant strain was suspended in 0.05 M phosphate buffer with 10% sucrose and used to dose mice. Suspension of FRIK 816-3 in phosphate buffer at doses of 103 and 104 CFU increased the number of positive fecal samples from 2 of 15 (13%) to 5 of 15 (33%) and from 4 of 15 (27%) to 10 of 15 (67%), respectively (Table 4). Early studies defining the infectious dose of Vibrio cholerae also demonstrated the importance of the gastric barrier, as suspension of V. cholerae in bicarbonate buffer reduced the infectious dose in humans from 108 to 104 organisms (5). Our study of E. coli O157:H7 used phosphate buffer instead of bicarbonate buffer because the latter reduced viable numbers of FRIK 816-3 (data not shown). The data from this study indicate that protection from acid afforded by rpoS-regulated systems promotes gastric passage.
A calf model of E. coli O157:H7 shedding was used to examine
the effect of the rpoS system on the survival and shedding
from the gastrointestinal tract of cattle. As in other studies using a
calf model (4, 9, 10), an inoculum of 1010 CFU
of the organism resulted in appreciable shedding during the first week
postinoculation. When the RpoS+ and RpoS
strains were simultaneously administered to calves, we were able to
compare numbers of each strain shed concurrently.
The RpoS
mutant (EK275) was reproducibly shed in lower
numbers from the calves than was its RpoS+ parent (EK274)
(Fig. 1), and this difference was significant (P < 0.05). This finding indicates that rpoS plays a role in
E. coli O157:H7 shedding in calves, possibly by inducing
resistance to gastrointestinal stress, including acid stress offset by
the glucose-repressed RpoS-dependent AR system.
The observation that strains of E. coli O157:H7 were shed in detectable numbers for several weeks reflects the fact that these calves were inoculated with high numbers of E. coli O157:H7 (ca. 1010 CFU) in order to achieve extended periods of shedding at appropriate numbers for detection. In the natural setting, cattle most likely ingest fewer organisms. Indeed, field observations indicate that exposure of cattle does not result in shedding of high numbers of E. coli O157:H7 strains for extended periods of time (31). What was unexpected about these results was the finding that both the parent and rpoS strains were shed for essentially the same length of time (data not shown). This observation may indicate that E. coli O157:H7 survivors that reach and colonize the lower intestinal tract, where the pH is neutral to alkaline, no longer require AR for survival.
The long-term goal of this study is to further define the role of AR systems in gastrointestinal passage and to develop intervention strategies that may inactivate one or more of these systems and possibly reduce or eliminate this pathogen from the bovine intestinal tract. Such an approach might be complementary to other strategies such as vaccination of herds with intimin, as suggested by Dean-Nystrom et al. (12), or manipulation of feed content (13, 22) as part of a complete program to exclude E. coli O157:H7 from cattle by reducing its ability to compete or survive in this complex digestive system. In the present work, a global regulator of acid and other stress resistance was shown to influence E. coli O157:H7 shedding from mice and calves. We are presently continuing experiments aimed at dissecting the role of each AR determinant in E. coli O157:H7.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants 97-02329 to J.W.F. and
94-37201-1025 to C.W.K. from the National Research Initiative
Competitive Grants Program of the U.S. Department of Agriculture.
C.W.K. was also supported by the College of Agriculture and Life
Sciences, University of Wisconsin
Madison. S.B.P., J.C.W., and F.J.D.
were supported by the Alabama Agricultural Experiment Station and the College of Veterinary Medicine, Auburn University.
We thank David Baumler, Mark Freeman, Tony Fuller, and Joey Minter for providing excellent technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Pathobiology, College of Veterinary Medicine, 264 Greene Hall, Auburn University, Auburn, AL 36849. Phone: (334) 844-2673. Fax: (334) 844-2652. E-mail: pricesb{at}vetmed.auburn.edu
Present address: Department of Infectious Diseases, St. Jude
Children's Research Hospital, Memphis, TN 38105.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bell, B. P., M. Goldoft, P. M. Griffin, M. A. Davis, D. C. Gordon, P. I. Tarr, C. A. Bartleson, J. H. Lewis, T. J. Barrett, J. G. Wells, R. B. Baron, and J. Kobayashi. 1994. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 272:1349-1353[Abstract]. |
| 2. | Besser, T. E., D. D. Hancock, L. C. Pritchett, E. M. McRae, D. H. Rice, and P. I. Tarr. 1997. Duration of detection of fecal excretion of Escherichia coli O157:H7 in cattle. J. Infect. Dis. 175:726-729[Medline]. |
| 3. | Besser, T. E., S. M. Lett, J. T. Weber, M. P. Doyle, T. J. Barrett, J. G. Wells, and P. M. Griffin. 1993. An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider. JAMA 269:2217-2220[Abstract]. |
| 4. | Brown, C. A., B. G. Harmon, T. Zhao, and M. P. Doyle. 1997. Experimental Escherichia coli O157:H7 carriage in calves. Appl. Environ. Microbiol. 63:27-32[Abstract]. |
| 5. | Cash, R. A., S. I. Music, J. P. Libonati, M. J. Snyder, R. P. Wenzel, and R. B. Hornick. 1974. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J. Infect. Dis. 129:45-52[Medline]. |
| 6. |
Castanie-Cornet, M.-P.,
T. A. Penfound,
D. Smith,
J. F. Elliott, and J. W. Foster.
1999.
Control of acid resistance in Escherichia coli.
J. Bacteriol.
181:3525-3535 |
| 7. |
Centers for Disease Control and Prevention.
1995.
Escherichia coli O157:H7 outbreak linked to commercially distributed dry-cured salami Washington and California 1994.
Morbid. Mortal. Weekly Rep.
44:157-160[Medline].
|
| 8. | Cheville, A. M., K. W. Arnold, C. Buchrieser, C.-M. Cheng, and C. W. Kaspar. 1996. rpoS regulation of acid, heat, and salt tolerance in Escherichia coli O157:H7. Appl. Environ. Microbiol. 62:1822-1824[Abstract]. |
| 9. |
Cray, W. C.,
T. A. Casey,
B. T. Bosworth, and M. A. Rasmussen.
1998.
Effect of dietary stress on fecal shedding of Escherichia coli O157:H7 in calves.
Appl. Environ. Microbiol.
64:1975-1979 |
| 10. | Cray, W. C., and H. W. Moon. 1995. Experimental infection of calves and adult cattle with Escherichia coli O157:H7. Appl. Environ. Microbiol. 61:1586-1590[Abstract]. |
| 11. | Dean-Nystrom, E. A., B. T. Bosworth, W. C. Cray, Jr., and H. W. Moon. 1997. Pathogenicity of Escherichia coli O157 in the intestines of neonatal calves. Infect. Immun. 65:1842-1848[Abstract]. |
| 12. |
Dean-Nystrom, E. A.,
B. T. Bosworth,
H. W. Moon, and A. D. O'Brien.
1998.
Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves.
Infect. Immun.
66:4560-4563 |
| 13. |
Diez-Gonzalez, F.,
T. R. Callaway,
M. G. Kizoulis, and J. B. Russell.
1998.
Grain feeding and the dissemination of acid-resistant Escherichia coli from cattle.
Science
281:1666-1668 |
| 14. | Faith, N. G., J. A. Shere, R. Brosch, K. W. Arnold, S. E. Ansay, M. S. Lee, J. B. Luchansky, and C. W. Kaspar. 1996. Prevalence and clonal nature of Escherichia coli O157:H7 on dairy farms in Wisconsin. Appl. Environ. Microbiol. 62:1519-1525[Abstract]. |
| 15. | Fenwick, B. W., and L. A. Cowan. 1998. Canine model of hemolytic-uremic syndrome, p. 268-277. In J. B. Kaper, and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D.C. |
| 16. |
Francis, D. H.,
J. E. Collins, and J. R. Duimstra.
1986.
Infection of gnotobiotic pigs with an Escherichia coli O157:H7 strain associated with an outbreak of hemorrhagic colitis.
Infect. Immun.
51:953-956 |
| 17. | Gabrielsson, J., and D. Weiner. 1994. Pharmacokinetic and pharmacodynamic data analysis, p. 94. Swedish Pharmaceutical Press, Stockholm, Sweden. |
| 18. | Gorden, J., and P. L. Small. 1993. Acid resistance in enteric bacteria. Infect. Immun. 61:364-367. |
| 19. | Griffin, P. M. 1995. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, p. 739-761. In M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg, and R. L. Guerrant (ed.), Infections of the gastrointestinal tract. Raven Press, New York, N.Y. |
| 20. |
Griffin, P. M., and R. V. Tauxe.
1991.
The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.
Epidemiol. Rev.
13:60-98 |
| 21. | Hancock, D. D., T. E. Besser, M. L. Kinsel, P. I. Tarr, D. H. Rice, and M. G. Paros. 1994. The prevalence of Escherichia coli O157:H7 in dairy and beef cattle in Washington State. Epidemiol. Infect. 113:199-207[Medline]. |
| 22. |
Hovde, C. J.,
P. R. Austin,
K. A. Cloud,
C. J. Williams, and C. W. Hunt.
1999.
Effect of cattle diet on Escherichia coli O157:H7 acid resistance.
Appl. Environ. Microbiol.
65:3233-3235 |
| 23. |
Jerse, A. E.,
J. Yu,
B. D. Tall, and J. B. Kaper.
1990.
A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.
Proc. Natl. Acad. Sci. USA
87:7839-7843 |
| 24. | Kudva, I. T., P. G. Hatfield, and C. J. Hovde. 1995. Effect of diet on the shedding of Escherichia coli O157:H7 in a sheep model. Appl. Environ. Microbiol. 61:1363-1370[Abstract]. |
| 25. |
Lin, J.,
I. S. Lee,
J. Frey,
J. L. Slonczewski, and J. W. Foster.
1995.
Comparative analysis of extreme acid survival in Salmonella typhimurium, Shigella flexneri, and Escherichia coli.
J. Bacteriol.
177:4097-4104 |
| 26. | Lin, J., P. Smith, K. C. Chapin, H. S. Baik, G. N. Bennett, and J. W. Foster. 1996. Mechanisms of acid resistance in enterohemorrhagic Escherichia coli. Appl. Environ. Microbiol. 62:3094-3100[Abstract]. |
| 27. |
Lindgren, S. W.,
A. R. Melton, and A. D. O'Brien.
1993.
Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model.
Infect. Immun.
61:3832-3842 |
| 28. | Miller, J. H. 1992. A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 29. | Myhal, M. L., P. S. Cohen, and D. C. Laux. 1983. Altered colonizing ability for mouse large intestine of a surface mutant of a human faecal isolate of Escherichia coli. J. Gen. Microbiol. 129:1549-1558[Medline]. |
| 30. | Myhal, M. L., D. C. Laux, and P. S. Cohen. 1982. Relative colonizing abilities of human fecal and K12 strains of Escherichia coli in the large intestine of streptomycin-treated mice. Eur. J. Clin. Microbiol. 1:186-192[CrossRef][Medline]. |
| 31. |
Shere, J. A.,
K. J. Bartlett, and C. W. Kaspar.
1998.
Longitudinal study of Escherichia coli O157:H7 dissemination on four dairy farms in Wisconsin.
Appl. Environ. Microbiol.
64:1390-1399 |
| 32. |
Vogel, H. J., and D. M. Bonner.
1956.
Acetylornithinase of Escherichia coli: partial purification and some properties.
J. Biol. Chem.
218:97-106 |
| 33. |
Wadolkowski, E. A.,
J. A. Burris, and A. D. O'Brien.
1990.
Mouse model for the colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7.
Infect. Immun.
58:2438-2445 |
| 34. |
Wells, J. G.,
B. R. Davis,
I. K. Wachsmuth,
L. W. Riley,
R. S. Remis,
R. Sokolow, and G. K. Morris.
1983.
Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.
J. Clin. Microbiol.
18:512-520 |
| 35. | Zadik, P. M., P. A. Chapman, and C. A. Siddons. 1993. Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157:H7. J. Med. Microbiol. 39:155-158[Abstract]. |
| 36. | Zar, J. H. 1984. Biostatistical analysis, p. 185-205. Prentice-Hall, Inc., Englewood Cliffs, N.J. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|